Species selectivity in poxviral complement regulators is dictated by the charge reversal in the central complement control protein modules

Journal of Immunology

Volumn 189, Issue 3, 2012, Pages 1431-1439

  Yadav, Viveka Nand ^a   Pyaram, Kalyani ^a   Ahmad, Muzammil ^a   Sahu, Arvind ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT; COMPLEMENT COMPONENT C3B; FIBRINOGEN; GLUTAMIC ACID; REGULATOR PROTEIN; SMALLPOX INHIBITOR OF COMPLEMENT ENZYME; UNCLASSIFIED DRUG; VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN;

ARTICLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; COW; MUTANT; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PURIFICATION; SITE DIRECTED MUTAGENESIS; SMALLPOX VIRUS; SURFACE PLASMON RESONANCE; VACCINIA VIRUS; VIRAL TROPISM;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CATTLE; COMPLEMENT C3B; COMPLEMENT FACTOR I; COMPLEMENT PATHWAY, ALTERNATIVE; HUMANS; IMMUNE EVASION; MOLECULAR SEQUENCE DATA; SPECIES SPECIFICITY; STATIC ELECTRICITY; VACCINIA VIRUS; VIRAL PROTEINS;

EID: 84864142391     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200946     Document Type: Article

References (46)

1. Moss, B. 2011. Smallpox vaccines: targets of protective immunity. Immunol. Rev. 239: 8-26.
2. Alibek, K. 2004. Smallpox: a disease and a weapon. Int. J. Infect. Dis. 8(Suppl 2): S3-S8. (Pubitemid 39445962)
3. Chen, Z., P. Earl, J. Americo, I. Damon, S. K. Smith, Y. H. Zhou, F. Yu, A. Sebrell, S. Emerson, G. Cohen, et al. 2006. Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus. Proc. Natl. Acad. Sci. USA 103: 1882-1887. (Pubitemid 43228787)
4. Reeves, P. M., B. Bommarius, S. Lebeis, S. McNulty, J. Christensen, A. Swimm, A. Chahroudi, R. Chavan, M. B. Feinberg, D. Veach, et al. 2005. Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases. Nat. Med. 11: 731-739. (Pubitemid 41021205)
5. Buller, R. M., and G. J. Palumbo. 1991. Poxvirus pathogenesis. Microbiol. Rev. 55: 80-122. (Pubitemid 21895147)
6. McFadden, G. 2005. Poxvirus tropism. Nat. Rev. Microbiol. 3: 201-213. (Pubitemid 40298220)
7. Lambris, J. D., D. Ricklin, and B. V. Geisbrecht. 2008. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6: 132-142.
8. Pyaram, K., V. N. Yadav, M. J. Reza, and A. Sahu. 2010. Virus-complement interactions: an assiduous struggle for dominance. Future Virol. 5: 709-730.
9. Walport, M. J. 2001. Complement: first of two parts. N. Engl. J. Med. 344: 1058-1066.
10. Dunkelberger, J. R., and W. C. Song. 2010. Complement and its role in innate and adaptive immune responses. Cell Res. 20: 34-50.
11. Carroll, M. C. 2004. The complement system in regulation of adaptive immunity. Nat. Immunol. 5: 981-986. (Pubitemid 41057714)
12. Rosengard, A. M., Y. Liu, Z. Nie, and R. Jimenez. 2002. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc. Natl. Acad. Sci. USA 99: 8808-8813. (Pubitemid 34693640)
13. Shchelkunov, S. N., R. F. Massung, and J. J. Esposito. 1995. Comparison of the genome DNA sequences of Bangladesh-1975 and India-1967 variola viruses. Virus Res. 36: 107-118.
14. Sfyroera, G., M. Katragadda, D. Morikis, S. N. Isaacs, and J. D. Lambris. 2005. Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins. J. Immunol. 174: 2143-2151. (Pubitemid 40223958)
15. Yadav, V. N., K. Pyaram, J. Mullick, and A. Sahu. 2008. Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation. J. Virol. 82: 3283-3294. (Pubitemid 351429907)
16. Liszewski, M. K., M. K. Leung, R. Hauhart, C. J. Fang, P. Bertram, and J. P. Atkinson. 2009. Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activity. J. Immunol. 183: 3150-3159.
17. Trindade, G. S., G. L. Emerson, D. S. Carroll, E. G. Kroon, and I. K. Damon. 2007. Brazilian vaccinia viruses and their origins. Emerg. Infect. Dis. 13: 965-972. (Pubitemid 47048066)
18. Isaacs, S. N., G. J. Kotwal, and B. Moss. 1992. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. USA 89: 628-632.
19. Kotwal, G. J., S. N. Isaacs, R. McKenzie, M. M. Frank, and B. Moss. 1990. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250: 827-830.
20. Moulton, E. A., P. Bertram, N. Chen, R. M. Buller, and J. P. Atkinson. 2010. Ectromelia virus inhibitor of complement enzymes protects intracellular mature virus and infected cells from mouse complement. J. Virol. 84: 9128-9139.
21. Girgis, N. M., B. C. Dehaven, Y. Xiao, E. Alexander, K. M. Viner, and S. N. Isaacs. 2011. The vaccinia virus complement control protein modulates adaptive immune responses during infection. J. Virol. 85: 2547-2556.
22. Bernet, J., M. Ahmad, J. Mullick, Y. Panse, A. K. Singh, P. B. Parab, and A. Sahu. 2011. Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity. Vaccine 29: 7435-7443.
23. Lachmann, P. J. 1991. The control of homologous lysis. Immunol. Today 12: 312-315.
24. Zipfel, P. F., and C. Skerka. 2009. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 9: 729-740.
25. Morgan, B. P., C. W. Berg, and C. L. Harris. 2005. "Homologous restriction" in complement lysis: roles of membrane complement regulators. Xenotransplantation 12: 258-265. (Pubitemid 40868327)
26. Mullick, J., J. Bernet, Y. Panse, S. Hallihosur, A. K. Singh, and A. Sahu. 2005. Identification of complement regulatory domains in vaccinia virus complement control protein. J. Virol. 79: 12382-12393. (Pubitemid 41346100)
27. Pangburn, M. K. 1987. A fluorimetric assay for native C3: the hemolytically active form of the third component of human complement. J. Immunol. Methods 102: 7-14. (Pubitemid 17151552)
28. Sahu, A., S. N. Isaacs, A. M. Soulika, and J. D. Lambris. 1998. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. J. Immunol. 160: 5596-5604. (Pubitemid 28267854)
29. Phipps, D., M. Menger, J. S. Chadwick, and W. P. Aston. 1987. A cobra venom factor (CVF)-induced C3 convertase activity in the hemolymph of Galleria mellonella. Dev. Comp. Immunol. 11: 37-46.
30. Singh, A. K., J. Mullick, J. Bernet, and A. Sahu. 2006. Functional characterization of the complement control protein homolog of herpesvirus saimiri: Arg-118 is critical for factor I cofactor activities. J. Biol. Chem. 281: 23119-23128.
31. Pang, A. S., and W. P. Aston. 1978. The alternative complement pathway in bovine serum: the isolation of a serum protein with factor B activity. Immunochemistry 15: 529-534. (Pubitemid 9069630)
32. Menger, M., and W. P. Aston. 2003. Isolation and characterization of factor I of the bovine complement system. Am. J. Vet. Res. 64: 989-993. (Pubitemid 36958220)
33. White, J., P. Lukacik, D. Esser, M. Steward, N. Giddings, J. R. Bright, S. J. Fritchley, B. P. Morgan, S. M. Lea, G. P. Smith, and R. A. Smith. 2004. Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli. Protein Sci. 13: 2406-2415. (Pubitemid 39128861)
34. Mullick, J., J. Bernet, A. K. Singh, J. D. Lambris, and A. Sahu. 2003. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins. J. Virol. 77: 3878-3881. (Pubitemid 36297309)
35. Pryzdial, E. L., and D. E. Isenman. 1986. A reexamination of the role of magnesium in the human alternative pathway of complement. Mol. Immunol. 23: 87-96. (Pubitemid 16206390)
36. Bernet, J., J. Mullick, Y. Panse, P. B. Parab, and A. Sahu. 2004. Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b. J. Virol. 78: 9446-9457. (Pubitemid 39096553)
37. McKenzie, R., G. J. Kotwal, B. Moss, C. H. Hammer, and M. M. Frank. 1992. Regulation of complement activity by vaccinia virus complement-control protein. J. Infect. Dis. 166: 1245-1250.
38. Lambris, J. D., A. Sahu, and R. Wetsel. 1998. The chemistry and biology of C3, C4, and C5. In The Human Complement System in Health and Disease. J. E. Volanakis, and M. Frank, eds. Marcel Dekker, New York, p. 83-118.
39. Gros, P., F. J. Milder, and B. J. Janssen. 2008. Complement driven by conformational changes. Nat. Rev. Immunol. 8: 48-58.
40. Kuttner-Kondo, L. A., M. P. Dybvig, L. M. Mitchell, N. Muqim, J. P. Atkinson, M. E. Medof, and D. E. Hourcade. 2003. A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases. J. Biol. Chem. 278: 52386-52391. (Pubitemid 38035829)
41. Lukacik, P., P. Roversi, J. White, D. Esser, G. P. Smith, J. Billington, P. A. Williams, P. M. Rudd, M. R. Wormald, D. J. Harvey, et al. 2004. Complement regulation at the molecular level: the structure of decay-accelerating factor. Proc. Natl. Acad. Sci. USA 101: 1279-1284. (Pubitemid 38182680)
42. Wu, J., Y. Q. Wu, D. Ricklin, B. J. Janssen, J. D. Lambris, and P. Gros. 2009. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat. Immunol. 10: 728-733.
43. Zhang, L., and D. Morikis. 2006. Immunophysical properties and prediction of activities for VCP and SPICE using molecular dynamics and electrostatics. Biophys. J. 90: 3106-3119.
44. Pyaram, K., C. A. Kieslich, V. N. Yadav, D. Morikis, and A. Sahu. 2010. Influence of electrostatics on the complement regulatory functions of Kaposica, the complement inhibitor of Kaposi's sarcoma-associated herpesvirus. J. Immunol. 184: 1956-1967.
45. Fredslund, F., L. Jenner, L. B. Husted, J. Nyborg, G. R. Andersen, and L. Sottrup-Jensen. 2006. The structure of bovine complement component 3 reveals the basis for thioester function. J. Mol. Biol. 361: 115-127. (Pubitemid 44043166)
46. Janssen, B. J., A. Christodoulidou, A. McCarthy, J. D. Lambris, and P. Gros. 2006. Structure of C3b reveals conformational changes that underlie complement activity. Nature 444: 213-216. (Pubitemid 44722062)